no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
An analysis of tumor-related skin temperature differences in malignant soft-tissue tumors
|
Shimatani, Akiyoshi |
|
|
27 |
1 |
p. 234-243 |
article |
2 |
A phase 2, open-label, multicenter study of ixazomib plus lenalidomide and dexamethasone in adult Japanese patients with relapsed and/or refractory multiple myeloma
|
Iida, Shinsuke |
|
|
27 |
1 |
p. 224-233 |
article |
3 |
Cancer in adolescents and young adults in Japan: epidemiology and cancer strategy
|
Nakata, Kayo |
|
|
27 |
1 |
p. 7-15 |
article |
4 |
Changes of cancer diagnosis disclosure to children in Japan in the last 20 years
|
Hori, Hiroki |
|
|
27 |
1 |
p. 245-252 |
article |
5 |
Chronological transition in outcome of second-line treatment in patients with metastatic urothelial cancer after pembrolizumab approval: a multicenter retrospective analysis
|
Isobe, Teruki |
|
|
27 |
1 |
p. 165-174 |
article |
6 |
Clinical impact of primary tumour 123ImIBG response to induction chemotherapy in children with high-risk neuroblastoma
|
Szychot, Elwira |
|
|
27 |
1 |
p. 253-261 |
article |
7 |
Clinical practice guideline for the treatment of malignant ascites: section summary in Clinical Practice Guideline for peritoneal dissemination (2021)
|
Matsusaki, Keisuke |
|
|
27 |
1 |
p. 1-6 |
article |
8 |
Comparison of treatment outcomes of pelvis external radiotherapy with and without vaginal brachytherapy for cervical cancer patients with positive or close vaginal resected margins
|
Lee, Yun Hee |
|
|
27 |
1 |
p. 202-212 |
article |
9 |
Correction to: An analysis of tumor-related skin temperature differences in malignant soft-tissue tumors
|
Shimatani, Akiyoshi |
|
|
27 |
1 |
p. 244 |
article |
10 |
Correction to: Medical guidelines for Li–Fraumeni syndrome 2019, version 1.1
|
Kumamoto, Tadashi |
|
|
27 |
1 |
p. 262-263 |
article |
11 |
Critical appraisal of epigenetic regulation of galectins in cancer
|
Gadwal, Ashita |
|
|
27 |
1 |
p. 35-44 |
article |
12 |
Current state of fertility preservation for adolescent and young adult patients with gynecological cancer
|
Ohara, Tatsuru |
|
|
27 |
1 |
p. 25-34 |
article |
13 |
Current status of AYA-generation breast cancer: trends worldwide and in Japan
|
Futamura, Manabu |
|
|
27 |
1 |
p. 16-24 |
article |
14 |
Deferred radical prostatectomy in patients who initially elected for active surveillance: a multi-institutional, prospective, observational cohort of the PRIAS-JAPAN study
|
Tohi, Yoichiro |
|
|
27 |
1 |
p. 194-201 |
article |
15 |
Heterogeneous distribution of PD-L1 expression in the IASLC/ATS/ERS classification of lung adenocarcinoma
|
Zhang, Dachuan |
|
|
27 |
1 |
p. 105-111 |
article |
16 |
How long is long enough to secure disease control after low-dose-rate brachytherapy in combination with other modalities in intermediate-risk, localized prostate cancer?
|
Urabe, Fumihiko |
|
|
27 |
1 |
p. 184-193 |
article |
17 |
Key promoters of tumor hallmarks
|
Mortezaee, Keywan |
|
|
27 |
1 |
p. 45-58 |
article |
18 |
Large and diffuse ductal carcinoma in situ: potentially lethal subtypes of “preinvasive” disease
|
O’Keefe, Thomas J. |
|
|
27 |
1 |
p. 121-130 |
article |
19 |
Osimertinib in poor performance status patients with T790M-positive advanced non-small-cell lung cancer after progression of first- and second-generation EGFR-TKI treatments (NEJ032B)
|
Tsubata, Yukari |
|
|
27 |
1 |
p. 112-120 |
article |
20 |
Outcomes of long-term nivolumab and subsequent chemotherapy in Japanese patients with head and neck cancer: 2-year follow-up from a multicenter real-world study
|
Yasumatsu, Ryuji |
|
|
27 |
1 |
p. 95-104 |
article |
21 |
Pembrolizumab plus axitinib versus sunitinib in metastatic renal cell carcinoma: outcomes of Japanese patients enrolled in the randomized, phase III, open-label KEYNOTE-426 study
|
Tamada, Satoshi |
|
|
27 |
1 |
p. 154-164 |
article |
22 |
Phase 2 study of axicabtagene ciloleucel in Japanese patients with relapsed or refractory large B-cell lymphoma
|
Kato, Koji |
|
|
27 |
1 |
p. 213-223 |
article |
23 |
Preoperative sarcopenia is a poor prognostic factor in lower rectal cancer patients undergoing neoadjuvant chemoradiotherapy: a retrospective study
|
Abe, Shinya |
|
|
27 |
1 |
p. 141-153 |
article |
24 |
Preoperative transferrin level is a novel indicator of short- and long-term outcomes after esophageal cancer surgery
|
Yamane, Taishi |
|
|
27 |
1 |
p. 131-140 |
article |
25 |
Presence of serum RalA and serum p53 autoantibodies in 1833 patients with various types of cancers
|
Nanami, Tatsuki |
|
|
27 |
1 |
p. 72-76 |
article |
26 |
Pretreatment clinical and hematologic prognostic factors of metastatic urothelial carcinoma treated with pembrolizumab: a systematic review and meta-analysis
|
Yanagisawa, Takafumi |
|
|
27 |
1 |
p. 59-71 |
article |
27 |
Retraction Note to: Inhibition of TMEM16A suppresses growth and induces apoptosis in hepatocellular carcinoma
|
Zhang, Chuantao |
|
|
27 |
1 |
p. 264 |
article |
28 |
Sarcopenia is associated with survival in patients with urothelial carcinoma treated with systemic chemotherapy
|
Shimizu, Ryutaro |
|
|
27 |
1 |
p. 175-183 |
article |
29 |
The Real-World status and risk factors for a poor prognosis in elderly patients with primary central nervous system malignant lymphomas: a multicenter, retrospective cohort study of the Tohoku Brain Tumor Study Group
|
Asano, Kenichiro |
|
|
27 |
1 |
p. 77-94 |
article |